Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | BMY | AMGN | GSK | GILD |
| Company | Adaptimmune Ther ADR | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.0300 | 49.41 | 333.93 | 42.84 | 83.37 |
| High | 1.0700 | 50.18 | 339.00 | 42.90 | 84.52 |
| Low | 1.0200 | 48.78 | 331.00 | 42.38 | 82.76 |
| Last | 1.0400 | 49.74 | 332.92 | 42.43 | 83.89 |
| Change | -0.0100 | +0.25 | +0.12 | -0.13 | +0.84 |
| % Change | -0.95% | +0.51% | +0.04% | -0.31% | +1.01% |
| Volume | 963,244 | 6,800,769 | 1,363,506 | 3,515,680 | 9,196,430 |
| 20-Day Average Volume | 1,111,037 | 8,508,599 | 1,736,125 | 3,544,029 | 6,437,867 |
| Previous Close | 1.0500 | 49.49 | 332.80 | 42.56 | 83.05 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1545 | 49.06 | 329.25 | 43.28 | 79.63 |
| 20-Day Raw Stochastic | 6.45% | 73.87% | 69.60% | 24.58% | 90.09% |
| 20-Day Relative Strength | 43.85% | 57.58% | 55.28% | 51.25% | 71.85% |
| Weighted Alpha | -21.14 | -9.39 | +25.51 | +13.01 | +18.22 |
| Today's Opinion | 24% Sell | 72% Buy | 88% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 24% Sell | 72% Buy | 88% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 8% Buy | 24% Buy | 72% Buy | 24% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.70% since 09/11/24 | +2.37% since 09/11/24 | +0.89% since 09/11/24 | -3.06% since 09/11/24 | +3.64% since 09/11/24 |
| Low | 1.0200 on 09/18/24 | 47.76 on 09/12/24 | 326.41 on 09/12/24 | 42.38 on 09/18/24 | 81.57 on 09/13/24 |
| High | 1.1650 on 09/13/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 43.62 on 09/16/24 | 84.89 on 09/12/24 |
| 1-Month | |||||
| %Chg | -3.70% since 08/16/24 | +0.77% since 08/16/24 | +3.57% since 08/16/24 | +2.79% since 08/16/24 | +13.70% since 08/16/24 |
| Low | 1.0200 on 09/18/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 41.28 on 08/19/24 | 73.27 on 08/19/24 |
| High | 1.3300 on 08/26/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 44.67 on 08/27/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | +18.18% since 06/18/24 | +21.88% since 06/18/24 | +8.80% since 06/18/24 | +3.61% since 06/18/24 | +32.84% since 06/18/24 |
| Low | 0.8250 on 06/26/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 37.81 on 07/02/24 | 64.86 on 06/20/24 |
| High | 1.4800 on 07/30/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 44.67 on 08/27/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | -29.25% since 03/18/24 | -3.59% since 03/18/24 | +22.89% since 03/18/24 | +0.69% since 03/18/24 | +14.51% since 03/18/24 |
| Low | 0.8250 on 06/26/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 37.81 on 07/02/24 | 62.07 on 05/31/24 |
| High | 1.6500 on 03/28/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 45.92 on 05/15/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 259,166 | 100,321,184 | 178,525,568 | 88,204,832 | 103,468,096 |
| Shares Outstanding, K | 246,825 | 2,027,100 | 536,435 | 2,072,482 | 1,245,853 |
| Annual Sales | 60,280,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | -113,870,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 128,230,000 | 12,201,000,000 | 8,388,000,000 | 9,950,400,000 | 6,954,000,000 |
| Last Quarter Net Income | 69,520,000 | 1,680,000,000 | 746,000,000 | 1,480,440,000 | 1,614,000,000 |
| 60-Month Beta | 2.21 | 0.46 | 0.61 | 0.66 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.27 on 08/12/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 1.09 on 07/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/12/24 | 10/31/24 | 10/29/24 | 11/06/24 | 11/05/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.378 on 08/16/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 08/16/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.49 | 18.02 | 10.47 | 17.69 |